OxTalks will soon be transitioning to Oxford Events (full details are available on the Staff Gateway). A two-week publishing freeze is expected in early Hilary to allow all events to be migrated to the new platform. During this period, you will not be able to submit or edit events on OxTalks. The exact freeze dates will be confirmed as soon as possible.
If you have any questions, please contact halo@digital.ox.ac.uk
We will welcome Andy Pearce from GSK to introduce us to GSK’s Discovery Partnerships with Academia (DPAc), an innovative approach to drug discovery through integrated partnerships. As a unit within GSK’s research and development organization, Andy’s team are dedicated to creating highly collaborative relationships with leading academic researchers focussed on the discovery of a novel medicine. They believe working closely together throughout the course of a drug discovery project and combining different strengths is a great way to develop new medicines that truly benefit patients.
The concept is simple but powerful: bring together the insight and creativity of the academic world with the drug discovery expertise, capabilities and resources needed to make a medicine.
Further information and project examples are available on the website: www.dpac.gsk.com
The DPAc programme is agnostic in the therapeutic areas that it will pursue projects in and works with both biopharmaceutical and small molecule modalities, and so speculative enquiries are welcomed in any area.
The seminar will run from 12:00-13:00 and then Andy will be available to ask questions over lunch which will be provided.
